老年特应性皮炎

doi:10.35541/cjd.20200655

Abstract

Abstract: 【Abstract】 In recent years, the category of atopic dermatitis （AD） has been updated in domestic and foreign guidelines, and elderly AD has been added as a subtype. The pathogenesis of elderly AD is related to heredity, skin barrier dysfunction, immune dysregulation and lifestyle. Most elderly AD patients have atypical clinical symptoms, and misdiagnosis is very common. To fully understand the pathogenesis and clinical characteristics of elderly AD, and to formulate individualized diagnosis and treatment plans based on clinical characteristics, are particularly important for improving the quality of life of patients and reducing the burden of the disease.

Key words: Dermatitis, atopic, Aged, Therapy, Clinical features

Zhang Xibao, Dong Liangjiao, Ye Ruixian, Liu Huanyan, Xiong Qiying. Atopic dermatitis in the elderly[J]. Chinese Journal of Dermatology, 2021, 54(5): 447-451.doi:10.35541/cjd.20200655

References ［33］

［1］	Nutten S. Atopic dermatitis: global epidemiology and risk factors［J］. Ann Nutr Metab, 2015,66 Suppl 1:8⁃16. doi: 10.1159/000370220.
［2］	Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey［J］. Allergy, 2018,73（6）:1284⁃1293. doi: 10.1111/all.13401.
［3］	Ha J, Lee SW, Yon DK. Ten⁃year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008⁃2017［J］. Clin Exp Pediatr, 2020,63（7）:278⁃283. doi: 10.3345/cep.2019.01291.
［4］	Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology［J］. Geriatr Gerontol Int, 2016,16 Suppl 1:75⁃86. doi: 10.1111/ggi.12771.
［5］	中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南（2020版）［J］. 中华皮肤科杂志, 2020,53（2）:81⁃88. doi: 10.35541/cjd.20191000.
［6］	Williamson S, Merritt J, De Benedetto A. Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks［J］. Br J Dermatol, 2020,182（1）:47⁃54. doi: 10.1111/bjd.17896.
［7］	Shoormasti RS, Sabetkish N, Kazemnejad A, et al. Are the most common food allergens in an Iranian atopic population compatible with worldwide reports? A systemic review and meta⁃analysis with molecular classification of frequent allergens［J］. Allergol Immunopathol （Madr）, 2019,47（6）:604⁃618. doi: 10. 1016/j.aller.2019.04.005.
［8］	Chello C, Carnicelli G, Sernicola A, et al. Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature［J］. Int J Dermatol, 2020,59（6）:716⁃721. doi: 10.1111/ijd.14891.
［9］	Scala E, Abeni D, Guerra EC, et al. β⁃1,3⁃glucanase rOle e 9 and MnSOD rAsp f 6 IgE reactivity are the signature of atopic dermatitis in the Mediterranean area［J］. Clin Exp Allergy, 2020,50（4）:487⁃498. doi: 10.1111/cea.13555.
［10］	Nomura T, Honda T, Kabashima K. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers［J］. Int Immunol, 2018,30（9）:419⁃428. doi: 10.1093/intimm/dxy015.
［11］	Wang S, Zhu R, Gu C, et al. Distinct clinical features and serum cytokine pattern of elderly atopic dermatitis in China［J］. J Eur Acad Dermatol Venereol, 2020,34（10）:2346⁃2352. doi: 10.1111/ jdv.16346.
［12］	Zhou L, Leonard A, Pavel AB, et al. Age⁃specific changes in the molecular phenotype of patients with moderate⁃to⁃severe atopic dermatitis［J］. J Allergy Clin Immunol, 2019,144（1）:144⁃156. doi: 10.1016/j.jaci.2019.01.015.
［13］	Dezoteux F, Astrid B, Chuffard M, et al. Atopic dermatitis in elderly adults［J］. Eur J Dermatol, 2019,29（4）:371⁃374. doi: 10. 1684/ejd.2019.3609.
［14］	Baum S, Porat S, Lyakhovitsky A, et al. Adult atopic dermatitis in hospitalized patients: comparison between those with childhood⁃onset and late⁃onset disease［J］. Dermatology, 2019,235（5）:365⁃371. doi: 10.1159/000499708.
［15］	Shaheen MS, Silverberg JI. Atopic dermatitis is associated with osteoporosis and osteopenia in older adults［J］. J Am Acad Dermatol, 2019,80（2）:550⁃551. doi: 10.1016/j.jaad.2018.05.026.
［16］	He H, Li R, Choi S, et al. Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis［J］. Ann Allergy Asthma Immunol, 2020,124（1）:70⁃78. doi: 10.1016/j.anai.2019.10.013.
［17］	Ahn HJ, Shin MK, Seo JK, et al. Cross⁃sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis［J］. Neuropsychiatr Dis Treat, 2019,15:1469⁃1478. doi: 10.2147/NDT.S191509.
［18］	Tanei R. Atopic dermatitis in older adults: a review of treatment options［J］. Drugs Aging, 2020,37（3）:149⁃160. doi: 10.1007/s40266⁃020⁃00750⁃5.
［19］	Angelova⁃Fischer I, Rippke F, Richter D, et al. Stand⁃alone emollient treatment reduces flares after discontinuation of topical steroid treatment in atopic dermatitis: a double⁃blind, randomized, vehicle⁃controlled, left⁃right comparison study［J］. Acta Derm Venereol, 2018,98（5）:517⁃523. doi: 10.2340/00015 555⁃2882.
［20］	Chang A, Chen SC, Osterberg L, et al. A daily skincare regimen with a unique ceramide and filaggrin formulation rapidly improves chronic xerosis, pruritus, and quality of life in older adults［J］. Geriatr Nurs, 2018,39（1）:24⁃28. doi: 10.1016/j.gerinurse.2017.05.002.
［21］	Howell AN, Ghamrawi RI, Strowd LC, et al. Pharmacological management of atopic dermatitis in the elderly［J］. Expert Opin Pharmacother, 2020,21（7）:761⁃771. doi: 10.1080/14656566. 2020.1729738.
［22］	Jaworek A, Szafraniec K, Pastuszczak M, et al. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis［J］. Pol Merkur Lekarski, 2019,46（276）:243⁃247.
［23］	Cao T, Tey HL, Yosipovitch G. Chronic pruritus in the Geriatric population［J］. Dermatol Clin, 2018,36（3）:199⁃211. doi: 10. 1016/j.det.2018.02.004.
［24］	Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 （PDE4） inhibitor for the topical treatment of atopic dermatitis （AD） in children and adults［J］. J Am Acad Dermatol, 2016,75（3）:494⁃503.e6. doi: 10.1016/j.jaad.2016.05.046.
［25］	Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents［J］. J Am Acad Dermatol, 2014,71（2）:327⁃349. doi: 10.1016/j.jaad.2014.03.030.
［26］	Wollenberg A, Barbarot S, Bieber T, et al. Consensus⁃based European guidelines for treatment of atopic eczema （atopic dermatitis） in adults and children: part II［J］. J Eur Acad Dermatol Venereol, 2018,32（6）:850⁃878. doi: 10.1111/jdv.14888.
［27］	Goujon C, Nicolas JF, Nosbaum A. Methotrexate in atopic eczema. Comments to: consensus⁃based European guidelines for treatment of atopic eczema （atopic dermatitis） in adults and children: part II［J］. J Eur Acad Dermatol Venereol, 2019,33（4）:e154⁃e155. doi: 10.1111/jdv.15386.
［28］	Katayama I, Aihara M, Ohya Y, et al. Japanese guidelines for atopic dermatitis 2017［J］. Allergol Int, 2017,66（2）:230⁃247. doi: 10.1016/j.alit.2016.12.003.
［29］	Drucker AM, Eyerich K, de Bruin⁃Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement［J］. Br J Dermatol, 2018,178（3）:768⁃775. doi: 10.1111/bjd.15928.
［30］	Napolitano M, Fabbrocini G, Scalvenzi M, et al. Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study［J］. Clin Exp Dermatol, 2020,45（7）:888⁃890. doi: 10.1111/ced.14260.
［31］	Nygaard U, Vestergaard C, Deleuran M. Emerging treatment options in atopic dermatitis: systemic therapies［J］. Dermatology, 2017,233（5）:344⁃357. doi: 10.1159/000484406.
［32］	Nezamololama N, Fieldhouse K, Metzger K, et al. Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib［J］. Drugs Context, 2020,9:2020⁃8⁃5. doi: 10.7573/dic.2020⁃8⁃5.
［33］	Guttman⁃Yassky E, Thaçi D, Pangan AL, et al. Upadacitinib in adults with moderate to severe atopic dermatitis: 16⁃week results from a randomized, placebo⁃controlled trial［J］. J Allergy Clin Immunol, 2020,145（3）:877⁃884. doi: 10.1016/j.jaci.2019.11.025.

[1]	Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434.
[2]	Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553.
[3]	Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354.
[4]	Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362.
[5]	Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358.
[6]	Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378.
[7]	Yan Kexin, Xu Xiulian. Nanomedicine: a new strategy for the diagnosis and treatment of melanoma [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230109-e20230109.
[8]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274.
[9]	Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection （2024） [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208.
[10]	Wang Qianqiu, Zheng Xiaoli, Du Fangzhi, Zhang Xu. Stop syphilis transmission: new situation and new strategies [J]. Chinese Journal of Dermatology, 2024, 57(3): 209-212.
[11]	Chinese Society of Dermatology, National Center for STD Control, Chinese Center for Disease Control and Prevention, China Dermatologist Association, Chinese Association Rehabilitation of Dermatology. Guideline for the diagnosis and treatment of Chlamydia trachomatis urogenital infection in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(3): 193-200.
[12]	Liu Jia, Gu Yinghua, He Xiaoning, . Treatment and disease burden of hereditary angioedema [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220205-e20220205.
[13]	Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578.
[14]	Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 0(2): 20220239-e20220239.
[15]	China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024） [J]. Chinese Journal of Dermatology, 2024, 57(2): 97-108.

Atopic dermatitis in the elderly

PDF

Knowledge

Abstract

Cite this article

share this article

References ［33］

Related Articles 15

Metrics

Comments

Recommended 10